Beryl Drugs

{
  "main_header": {
    "sid": 302214,
    "name": "Beryl Drugs",
    "stock_name": "Beryl Drugs",
    "full_name": "Beryl Drugs Ltd",
    "name_url": "stocks-analysis/beryl-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "20.44",
    "chg": 0.34,
    "chgp": "1.69%",
    "dir": 1,
    "prev_price": "20.10",
    "mcapval": "10.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524606,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE415H01017",
    "curr_date": "May 21",
    "curr_time": "",
    "bse_nse_vol": "4.92 k",
    "exc_status": "Active",
    "traded_date": "May 21, 2026",
    "traded_date_str": "2026 05 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/beryl-drugs-302214-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Beryl Drugs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-beryl-drugs-ltd-4003788",
        "imagepath": "",
        "date": "2026-05-21 23:17:54",
        "description": "The next results date for Beryl Drugs Ltd is scheduled for 28 May 2026...."
      },
      {
        "title": "Beryl Drugs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/beryl-drugs-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3978899",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BerylDrugsLtd_mojoScore_3978899.png",
        "date": "2026-05-07 08:04:16",
        "description": "Beryl Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 6 May 2026. This revision reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals despite some valuation appeal and rising promoter confidence."
      },
      {
        "title": "Beryl Drugs Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/beryl-drugs-ltd-upgraded-to-sell-on-technical-improvements-despite-flat-financials-3936551",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BerylDrugsLtd_mojoScore_3936551.png",
        "date": "2026-04-08 08:05:39",
        "description": "Beryl Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 7 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing challenges in its financial performance and valuation metrics."
      },
      {
        "title": "Beryl Drugs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/beryl-drugs-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3879194",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BerylDrugsLtd_mojoScore_3879194.png",
        "date": "2026-03-09 08:04:19",
        "description": "Beryl Drugs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 6 March 2026. This shift reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, despite an attractive valuation. The company’s stock price has also suffered, declining 7.10% on the day of the downgrade, underscoring investor concerns."
      },
      {
        "title": "Beryl Drugs Ltd Stock Falls to 52-Week Low of Rs.15.92",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beryl-drugs-ltd-stock-falls-to-52-week-low-of-rs1592-3869179",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BerylDrugsLtd_priceRelatedfactors_3869179.png",
        "date": "2026-03-04 10:40:43",
        "description": "Beryl Drugs Ltd’s share price declined to a fresh 52-week low of Rs.15.92 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent challenges faced by the company within the Pharmaceuticals & Biotechnology sector, as it continues to underperform both its sector peers and broader market indices."
      },
      {
        "title": "Beryl Drugs Ltd Stock Falls to 52-Week Low of Rs.16.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/beryl-drugs-ltd-stock-falls-to-52-week-low-of-rs162-amidst-continued-downtrend-3865459",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BerylDrugsLtd_priceRelatedfactors_3865459.png",
        "date": "2026-03-02 14:15:14",
        "description": "Beryl Drugs Ltd’s shares declined sharply to a fresh 52-week low of Rs.16.2 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics."
      },
      {
        "title": "Why is Beryl Drugs Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-beryl-drugs-ltd-fallingrising-3861791",
        "imagepath": "",
        "date": "2026-02-28 01:08:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Volatility</strong></p>\n<p>The stock’s decline on 27-Feb was marked by heightened volatility, with an intraday price range of ₹2.14 and a low point of ₹19.61, representing a near 9.84% drop from previous levels. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure throughout the session. Such erratic trading behaviour, including a missed trading day in the last 20 sessions, underscores the stock’s current instability.</p>\n<p><strong>Underperformance Against Benchmarks</strong></p>\n<p>Beryl Drugs has consistently lagged behind the broader market indices and its sector over multiple time horizons. Over the past week, the stock declined by 7.66%, significantly underperforming the Sensex’s modest..."
      }
    ],
    "total": 280,
    "sid": "302214",
    "stock_news_url": "https://www.marketsmojo.com/news/beryl-drugs-302214"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consider And Approve The Audited Financial Statement Including Balance Sheet As At 31St March 2026 Statement Of Profit And Loss Cash Flow And Notes Thereon For The Year Ended 31St March 2026.",
      "datetime": "20-May-2026",
      "details": "Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve consider and approve the Audited Financial Statement including Balance Sheet as at 31st March 2026 Statement of Profit and Loss Cash Flow and Notes thereon for the year ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "PROCEEDINGS OF EGM",
      "datetime": "13-May-2026",
      "details": "PROCEEDINGS OF EGM",
      "source": "BSE"
    },
    {
      "caption": "ANNOUNCEMENT UBDER REGULATION 44 VOTING RESULTS OF EGM HELD ON 11TH MAY 2026",
      "datetime": "12-May-2026",
      "details": "VOTING RESULTS OF EGM HELD ON 11.05.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "28 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Beryl Drugs Ltd?

2026-05-21 23:17:54

The next results date for Beryl Drugs Ltd is scheduled for 28 May 2026....

Read full news article

Beryl Drugs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-05-07 08:04:16

Beryl Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 6 May 2026. This revision reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals despite some valuation appeal and rising promoter confidence.

Read full news article

Beryl Drugs Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials

2026-04-08 08:05:39

Beryl Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 7 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing challenges in its financial performance and valuation metrics.

Read full news article

Beryl Drugs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-03-09 08:04:19

Beryl Drugs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 6 March 2026. This shift reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, despite an attractive valuation. The company’s stock price has also suffered, declining 7.10% on the day of the downgrade, underscoring investor concerns.

Read full news article

Beryl Drugs Ltd Stock Falls to 52-Week Low of Rs.15.92

2026-03-04 10:40:43

Beryl Drugs Ltd’s share price declined to a fresh 52-week low of Rs.15.92 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent challenges faced by the company within the Pharmaceuticals & Biotechnology sector, as it continues to underperform both its sector peers and broader market indices.

Read full news article

Beryl Drugs Ltd Stock Falls to 52-Week Low of Rs.16.2 Amidst Continued Downtrend

2026-03-02 14:15:14

Beryl Drugs Ltd’s shares declined sharply to a fresh 52-week low of Rs.16.2 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics.

Read full news article

Why is Beryl Drugs Ltd falling/rising?

2026-02-28 01:08:58

Recent Price Movement and Volatility

The stock’s decline on 27-Feb was marked by heightened volatility, with an intraday price range of ₹2.14 and a low point of ₹19.61, representing a near 9.84% drop from previous levels. The weighted average price indicates that a larger volume of shares traded closer to the day’s low, signalling selling pressure throughout the session. Such erratic trading behaviour, including a missed trading day in the last 20 sessions, underscores the stock’s current instability.

Underperformance Against Benchmarks

Beryl Drugs has consistently lagged behind the broader market indices and its sector over multiple time horizons. Over the past week, the stock declined by 7.66%, significantly underperforming the Sensex’s modest...

Read full news article

View All News